CVE-2025-61940: high-severity vulnerability in Mirion Medical EC2 Software NMIS BioDose
Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
No sign of exploitation. No public exploitation artifact known so far.
The NMIS/BioDose software uses a shared database account that all users access through, with passwords checked only in the application itself rather than the database. This means if someone bypasses the application, they can directly access the database with full permissions.
CVE-2025-61940 exploits client-side authentication enforcement (CWE-603) where NMIS/BioDose V22.02 and earlier use a common SQL Server service account for all database connections. Authentication is validated only at the application layer; an attacker with network access to the database can bypass client software restrictions and directly query the database using the shared credentials, compromising data confidentiality and integrity.
In the same product, most dangerous first.